Roxanol and Foot deformity - a phase IV clinical study of FDA data

Summary:

Foot deformity is reported as a side effect among people who take Roxanol (morphine sulfate), especially for people who are female, 60+ old, also take Zometa, and have Hepatitis c.

The phase IV clinical study analyzes which people have Foot deformity when taking Roxanol. It is created by eHealthMe based on reports of 804 people who have side effects when taking Roxanol from the FDA, and is updated regularly.

What is Roxanol?

Roxanol has active ingredients of morphine sulfate. eHealthMe is studying from 807 Roxanol users. Check the latest studies of Roxanol.

What is Foot deformity?

Foot deformity (functional disability of foot) is found to be associated with 912 drugs and 705 conditions by eHealthMe. Check the latest studies of Foot deformity.

On Jul, 20, 2026

804 people reported to have side effects when taking Roxanol.
Among them, 14 people (1.74%) have Foot deformity.

Among these 14 people:

What is the gender of people who have Foot deformity when taking Roxanol? *

female: 76.92 %
male: 23.08 %

What is the age of people who have Foot deformity when taking Roxanol? *

What are other drugs people take besides Roxanol? *

What are other side effects people have besides Foot deformity? *

Fungal Nail Infection: 14 people, 100.00%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 14 people, 100.00%
Atelectasis (partial or complete collapse of the lung): 14 people, 100.00%
Oedema Peripheral (superficial swelling): 14 people, 100.00%
Neuropathy Peripheral (surface nerve damage): 14 people, 100.00%
Back Pain: 13 people, 92.86%
Stress And Anxiety: 13 people, 92.86%
Metastases To Bone (cancer spreads to bone): 12 people, 85.71%
Gait Disturbance: 12 people, 85.71%
Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 12 people, 85.71%

What are the existing conditions these people have? *

Osteoporosis (bones weak and more likely to break): 1 person, 7.14%
Neoplasm Malignant (cancer tumour): 1 person, 7.14%
Metastases To Bone (cancer spreads to bone): 1 person, 7.14%
Hepatitis C: 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Roxanol and have Foot deformity?

- Check whether Foot deformity is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Roxanol:

Roxanol (807 reports)

Foot deformity treatments and more:

Foot deformity (14,397 reports)

Browse all side effects of Roxanol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Foot deformity:

Foot deformity (912 drugs)

Browse all the conditions that are associated with Foot deformity:

Foot deformity (705 conditions)

Related publications that referenced our studies

Rasmy A, Rahal M, Kisana M, Ahmad S, Salah A, "Morphine induced thrombocytopenia: A case report", Journal of Case Reports and Images in Oncology, 2015 Dec .
Rasmy A, Rahal M, Kisana M, Ahmad S, Salah A, "Morphine induced thrombocytopenia: A case report", Journal of Case Reports and Images in Oncology, 2015 Dec .

How the study uses the data?

The study uses data from the FDA. It is based on morphine sulfate (the active ingredients of Roxanol) and Roxanol (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.